Socio Today
The landscape of neonatal health in Indonesia faces a persistent and complex challenge in the form of Congenital Heart Disease (CHD), a condition where the heart’s structure is malformed from birth. While the precise etiology of CHD remains largely idiopathic, medical experts are increasingly identifying specific environmental and physiological risk factors that, if managed correctly during pregnancy, could significantly reduce the incidence of these life-threatening anomalies. Dr. Rizky Adriansyah, a prominent pediatric specialist and the Chairman of the Cardiology Coordination Unit of the Indonesian Pediatric Society (IDAI), recently highlighted the critical window of intervention that exists before a child is even born, urging a national shift toward better prenatal education and more robust early screening protocols.
Speaking at a specialized health webinar, Dr. Rizky underscored that while CHD is not always a direct result of a single cause-and-effect relationship, several preventable factors play a disproportionate role in its development. The medical community has reached a consensus on at least three primary risk factors that have gained significant attention in contemporary medical literature: maternal infections, nutritional deficiencies, and the intake of specific medications during the first trimester of pregnancy. By addressing these variables, health authorities believe that the trajectory of neonatal mortality in Indonesia could be drastically altered.
The Triad of Prenatal Risk Factors
The formation of the human heart is a complex biological process that occurs very early in the gestational period, often before a woman even realizes she is pregnant. During this sensitive phase, external disruptions can lead to permanent structural defects. Dr. Rizky identified the Rubella virus, commonly known as German Measles, as one of the most potent threats to fetal cardiac development. When a pregnant woman contracts Rubella, the virus can cross the placental barrier, leading to Congenital Rubella Syndrome (CRS), which frequently manifests as patent ductus arteriosus or pulmonary artery stenosis in the newborn.
In addition to viral threats, nutritional status serves as a cornerstone of fetal health. A deficiency in folic acid (Vitamin B9) has long been linked to neural tube defects, but recent clinical evidence reinforces its vital role in cardiac morphogenesis. Dr. Rizky noted that many mothers in Indonesia still lack adequate access to or awareness of folic acid supplementation, which is essential for proper cell division and the formation of the heart’s chambers and valves.
The third major risk factor involves the consumption of certain pharmaceutical agents. Specifically, medications used to treat epilepsy or seizures, such as valproate, have been identified as teratogenic, meaning they can interfere with the development of an embryo. While managing chronic conditions like epilepsy is necessary for the mother’s safety, Dr. Rizky emphasized that such treatments must be strictly monitored and adjusted by medical professionals during pregnancy to mitigate the risk of CHD. While lifestyle factors such as smoking and alcohol consumption were traditionally viewed as the primary culprits, Dr. Rizky pointed out that CHD frequently occurs in infants whose mothers had no history of tobacco or alcohol use, suggesting that the "triad" of infection, nutrition, and medication deserves more urgent public health focus.
Statistical Reality and the Global Context
The urgency of addressing CHD is reflected in the sobering statistics provided by both national and international health bodies. According to data from the World Health Organization (WHO), approximately one out of every 100 newborns globally is diagnosed with some form of CHD. Of these cases, an estimated 25 percent are categorized as "Critical Congenital Heart Disease" (CCHD), a subset of conditions that require surgical intervention or catheterization within the first year—and often the first days—of life.
In the Indonesian context, the impact of CHD is even more pronounced. Data from 2017 indicates that CHD is the second leading cause of neonatal death in the country, accounting for 17 percent of all fatalities in the newborn period, surpassed only by complications related to prematurity. This translates to an incidence rate of two to four critical CHD cases per 1,000 live births. Despite the high prevalence, the Indonesian healthcare system struggles to keep pace with the demand for specialized care. Dr. Rizky revealed that currently, less than 50 percent of CHD cases in Indonesia receive the necessary medical or surgical treatment.
Several systemic barriers contribute to this treatment gap. The vast geography of the Indonesian archipelago creates significant logistical hurdles, as many specialized cardiac centers are concentrated in major urban hubs like Jakarta. Furthermore, there is a marked shortage of pediatric cardiologists and cardiovascular surgeons, coupled with a lack of advanced diagnostic equipment in rural healthcare facilities. Perhaps most critically, a general lack of public awareness regarding the symptoms of heart disease in infants often leads to late-stage diagnoses, where the window for successful intervention has already closed.
Advancements in Early Detection and Screening
To combat the high mortality rate, the medical community is advocating for the implementation of simplified yet highly effective screening methods. One of the most significant advancements in this area is the use of pulse oximetry for newborn screening. This non-invasive test measures the oxygen saturation levels in a baby’s blood and is considered a sensitive, fast, and cost-effective tool for detecting CCHD before the infant shows outward signs of distress.
Dr. Rizky explained that the procedure involves placing sensors on the baby’s right hand and either foot, typically between 24 and 48 hours after birth. A significant discrepancy in oxygen levels or a consistently low reading can alert healthcare providers to an underlying heart defect that might not be audible through a traditional stethoscope. This "oximetry screening" is particularly vital because many babies with critical heart defects appear healthy immediately after birth, only to collapse once the ductus arteriosus—a temporary blood vessel in the fetal heart—closes in the days following delivery.
In addition to oximetry, the traditional stethoscope remains a fundamental tool. The presence of a "murmur" or an unusual sound during a heartbeat is often the first clinical sign of a heart issue. If a murmur is detected, Dr. Rizky insists that a referral for an echocardiography (an ultrasound of the heart) must be prioritized. Echocardiography serves as the definitive diagnostic tool, allowing specialists to visualize the heart’s structure and function in real-time.
The Role of Primary Care and Public Education
Bridging the gap in CHD care requires a decentralized approach that empowers primary healthcare providers, particularly midwives and general practitioners in rural areas. Dr. Rizky highlighted that the screening process, including oximetry, takes less than five minutes and can be easily performed by trained midwives. By integrating CHD screening into the standard postnatal care package, Indonesia could significantly increase the early detection rate.
To support this mission, IDAI has launched educational initiatives aimed at both healthcare professionals and the general public. One such resource is the "Sehatkan Jantung Anak Indonesia" (Heal the Hearts of Indonesian Children) YouTube channel. This platform provides accessible information on how to conduct screenings and what symptoms parents should watch for.
Among the clinical symptoms that parents must be aware of is poor weight gain. Because a struggling heart requires more energy, infants with CHD often experience "failure to thrive," where they tire easily during feeding and fail to meet growth milestones. In more severe or cyanotic cases, a bluish tint to the skin, lips, or fingernails may be visible, indicating a lack of oxygenated blood.
Broader Implications and the Path Forward
The implications of unmanaged CHD extend beyond individual health, impacting the socio-economic fabric of the nation. Children with untreated heart defects often face a lifetime of chronic illness, which places a heavy burden on the national healthcare budget and reduces the future productivity of the workforce. By shifting the focus toward prevention (through Rubella vaccination and folic acid fortification) and early detection (through universal newborn screening), Indonesia can improve the quality of life for thousands of children.
The call to action from experts like Dr. Rizky Adriansyah is clear: the fight against congenital heart disease begins in the prenatal clinic and the delivery room. While the medical technology to treat heart defects exists, its success depends entirely on the speed of diagnosis. As Indonesia continues to modernize its healthcare infrastructure, the integration of CHD screening into routine maternal and child health services remains a top priority.
In conclusion, the prevention of CHD is a multifaceted challenge that requires the cooperation of government agencies, healthcare providers, and the community at large. Ensuring that every pregnant woman is vaccinated against Rubella and has access to essential micronutrients is the first line of defense. Following birth, the simple application of a pulse oximeter could be the difference between life and death for the one in 100 children born with a broken heart. Through education, early intervention, and expanded access to specialized care, Indonesia can aim to lower the 17 percent neonatal mortality rate and ensure a healthier future for its next generation.
